Tag : CMED

Cannabis News Global Market Watch

Aurora Cannabis Finalizes Acquisition of CanniMed Therapeutics

Editor
Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF) announced this morning that the company has finalized acquisition of 95% of CanniMed Therapeutics (TSX: CMED) outstanding shares to complete “the largest acquisition in cannabis industry history.” Aurora Cannabis plans to acquire the remaining of CanniMeds outstanding shares through compulsory share acquisition. By completing...
Cash Crop 150 CCT Impact

Top 10 Public Companies with the Largest Market Caps in Cannabis

Editor
10. Emerald Health Therapeutics Inc. (TSX: EMH) $674 Million Emerald Health Therapeutics, Inc. operates through Emerald Health Therapeutics Canada Inc. (“EHTC”), a wholly owned subsidiary and Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations. Through EHTC, Emerald is authorized to produce and sell dried cannabis and cannabis oil for...
Cannabis News Health Hemp News Market Watch

CanniMed Releases New Product Line – CanniMed Topical Cream

Editor
On February 28, 2018, CanniMed Therapeutics Inc. (TSX: CMED) announced that the company had started fulfilling orders and shipping CanniMed® Topical Cream Kits to registered patients. This new product was a fusion of CanniMed’s medical cannabis oil with Kalaya™ Carrier Base Gel, created by Avaria Health & Beauty Corp. (“Avaria”),...
Cannabis News Market Watch

Aurora Cannabis Receives Regulatory Approval for CanniMed Acquisition

Editor
On February 28, 2018, Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) announced that it had received a No Action Letter from the Competition Bureau (Canada) regarding its offer to purchase all of the issued and outstanding common shares of CanniMed Therapeutics Inc. (CSE: CMED) that it does not already own. ...